Phase 4 Stroke Trial, Recruiting (NCT07119021)

Phase 4 Stroke Trial, Recruiting NCT07119021 Sponsor: Ruijun Ji Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT07119021 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 18 and 80 years old
People who have had an acute ischemic stroke (a stroke caused by a blocked blood vessel) that has been confirmed by a CT scan of the brain, using the definition set by the World Health Organization
People whose stroke symptoms began within the last 4.5 hours
People whose stroke severity falls within a specific range on a standard medical stroke scoring scale (a score of 6–24 on the NIHSS, which measures things like movement, speech, and vision — confirm with trial site)
People who are considered suitable for a standard clot-dissolving treatment given through a drip, based on international medical guidelines
People who have given their own consent, or whose family has given consent on their behalf

Who may not be able to join:

People who are pregnant, currently in labour, or who have recently given birth
People who have another serious illness that could make it difficult to assess how well they recover from the stroke
People who have another serious illness that could interfere with analysing their longer-term outcomes
People who have another serious illness where life expectancy is less than one year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07119021

Sponsor: Ruijun Ji

Phase: Phase 4

Status: Recruiting

Condition: Stroke

More information: https://clinicaltrials.gov/study/NCT07119021

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 18 and 80 years old
People who have had an acute ischemic stroke (a stroke caused by a blocked blood vessel) that has been confirmed by a CT scan of the brain, using the definition set by the World Health Organization
People whose stroke symptoms began within the last 4.5 hours
People whose stroke severity falls within a specific range on a standard medical stroke scoring scale (a score of 6–24 on the NIHSS, which measures things like movement, speech, and vision — confirm with trial site)
People who are considered suitable for a standard clot-dissolving treatment given through a drip, based on international medical guidelines
People who have given their own consent, or whose family has given consent on their behalf

Who may not be able to join:

People who are pregnant, currently in labour, or who have recently given birth
People who have another serious illness that could make it difficult to assess how well they recover from the stroke
People who have another serious illness that could interfere with analysing their longer-term outcomes
People who have another serious illness where life expectancy is less than one year

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Ruijun Ji

Registry

ClinicalTrials.gov

Start date

1 August 2024

Est. completion

30 April 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Primary endpoint indicators

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov